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INTRODUCTION 
lnformation about the visiting scientist 
The visiting scientist is working as a senior scientist at the department of Food Safety and 
Health (formerly the department of Risk Assessment and Toxicology) of the State lnstitute 
for Quality Control of Agricultural Products (RIKILT-DLO) seated at Wageningen, The 
Netherlands. RIKILT-DLO is a research institute of the Agricultual Research Department 
of the Ministry of Agriculture, Nature Management and Fisheries. At this institute 
analytica! and toxicological research is carried out in order to assess the quality and safety 
of food products and food production chains. At the department of Food Safety and 
Health, foods or compounds present in foods are studied which may influence the health 
of the consumer in a negative or positive manner. Compounds of interest can be divided 
into two major groups, namely contaminants like polychlorinated organic compounds, 
natura I toxins and residues of veterinary drugs and health promoting agents like vitamines 
and (iso-)flavonoids. The main task of the undersigned is to study the kinetics of these 
compounds in order to assess possible harmful or benificial effects in humans or food-
producing animals. For various reasons the applicant is interested in physiologically based 
pharmacokinetic (PB-PK) modeling. 
lnformation about the host institute 
The Pharmacokinetics Group within the Department of Pharmacy, University of 
Manchester, is one of the premier groups within the world engaged in all facets of 
pharmacokinetics - theory, experimental, rnadeling and data analysis. There are few such 
eentres within Europe, and none specifically within The Netherlands. 
Th is group, under the supervision of prof. dr. M. Rowland, is well known for its scientific 
contributions in physiologically based pharmacokinetics, which extend over 17 years. In 
addition to theoretica I developments, much of the research has been carried out in isolated 
perfused organs and whole animal studies, invariably in the rat, for which it has all the 
necessary experimental facilities . Also available are computer systems and software for 
model simulation and data analysis. 
Aims 
Geneml. _F..hannac.okinetic modcls are used to describe in mathematical term~_t!le time 
course of drug and metabolite concentrations in body fluids and tissues. A novel approach 
is the application of physiologically based pharmacokinetic (PB-PK) mode Is. These PB-PK 
models have been used to describe drug disposition in laboratory animals (mostly rats) and 
in humans (only recently). lt is our purpose to apply these models for descrihing and 
predicting drug and metabolite concentrations in food-producing animals and to study the 
kinetic behaviour of food compounds in man. The general aim is to gain insight in and 
knowledge of PB-PK modeling by means of a sabbatical leave of six months. Due to this 
short period a specified project was designed to perform fundamental research on hepatic 
dispersion and disposition. 
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Specific. Processes occuring in the liver are very important for the description of the 
kinetic behaviour of drugs and compounds present in food. Therefore this research was 
focussed on dispersion and distribution processes occuring in the rat liver. Polyethylene 
glycols were used as test compounds because they are mixtures of different oligomers and 
offer a set of molecules with different molecular weights and sizes. The aim was to study 
the influence of molecular size on the permeability of different oligomers of polyethylene 
glycol (PEG) in the isolated perfused rat liver. Furthermore, the feasibility of performing 
these studies with non-radioactive labelled PEGs was studied. 
Grant 
The Netherlands Organisation for Scientific Research (NWO), in collaboration with the 
British Council, provided a grant for international travel and subsistenee which covered 
a period of three months . 
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1. PHYSICO-CHEMICAL PROPERTIES OF PEG OLIGOMERS 
1 .1 General properties and nomendature 
Polyethylene glycols (PEGs) represent a family of inert, synthetic, linear polymers 
employed as viscosity enhancing agents, solubilizing agents and lubricants in a wide 
variety of commercial settings, including the pharmaceutical, cosmetic and food 
industries. PEGs arealso referred to as macrogols. Some authorities use the general 
formula H.(CH2.0.CH2)111.0H to describe PEGs [1]. In using this formula the 
number asssigned to m for a specified PEG is 1 more than that of n in the general 
formula CH20H. [CI-12. 0. CH21w CH20H which is used to describe the macrogoJs 
in this report. The PEGs are mixtures of condensation polymers of ethylene oxide 
and water. Those with an average molecular weight (MW) of 200 to 700 Dalton 
(Da) are liquid; those with an average MW of more than 1000 Da vary in 
consistenee from soft unctuous to hard wax-like solids. The average molecular 
weight is indicated by a number in the name; thus PEG400 has an average 
molecular weight of about 400 Da. The different oligomers are sametimes indicated 
by the letter 'E' foliowed by a number indicating the number (n) of CH2.0.CH2 
moieties. This means that E6 has a molecular weight of 326 Da. Molecular 
structures and weights of tested PEG oligomers are given in annex 1. 
1.2 Solubility and hydrophilicity of PEG400 and PEG600 oligomers 
The liquid and semi-solid PEGs are hygroscopic and miscible with water, alcohol, 
acetone, chloroform and withother glycols. They are practically insoluble in ether 
and aliphatic hydrocarbons but soluble in aromatic hydrocarbons. 
PEG400 is a mixture of eligomers with an average molecular weight of no less than 
380 and no more than 420 Da. It is a colourless, viscous liquid with a freezing 
point of about 3 oe and a specific gravity of 1.13 g/ml. PEG600 is a mixture of 
eligomers with an average molecular weight of 570-630 Da. It is a colourless, 
viscous liquid at room temperture with a freezing point of about 20°C and a 
specific gravity of 1.13 g/ml. A 5% w/v salution in water has a pH of 4.5 to 7. 
Various partition coefficients have been described in the literature [2-5]. It is 
difficult to campare these results due to different organic solvents used in the lipid-
water systems. The_partition coefficient (P) in an actanol-water srstem varied from 
0.01 to 0.0001 [4,5]. Furthermore, there is no complete agreement on the 
relationship between molecular weight and partition coefficient of the different 
oligomers. Theoretically, as the chain length increases with a constant molecular 
fragment (namely C2H40) the lipöphilicity would increase with a constant factor if 
no other processes (interactions) would be involved . However, only one paper 
described an increase of P with increasing molecular weight. Unfortunately none 
of the above-mentioned studies has been carried out according to the 'Shake-Flask' 
method as described in the OECD test guideline [6]. 
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2. DETERMINATION OF PEG OLIGOMERS WITH HPLC 
2.1 Introduetion 
The HPLC analysis of Iow-molecular weight PEGs has mostly been carried out 
with reversed-phase HPLC [5,7,8]. Stationary phases used were C18, C8 or styrene 
divinylbenzene analytica! columns. Mobile phases usually consisted of mixtures of 
water and methanol. Also size exclusion (gel filtration) columns have been used for 
the determination of PEGs in hu man urine [9]. 
All methods applied isoeratic elution of the eligomers resulting in relatively long 
run times (20-30 minutes) for single PEGs. If detection limits were low, or high 
concentrations were used, more eligomers could be detected and run times were 
even longer. 
Due to the absence of UV -absorption of PEGs most methods applied refractive 
index detection. 
The purpose of this study was to develop a rapid HPLC method with refractive 
index detection for the determination of a large number of eligomers (n > 12) in 
media used for rat Iiver perfusions. Mixing PEG400 and PEG600 allowed us to 
study oligomers with a range in molecular weight from 326 ( = E6) to 854 ( = E18), 
in some cases even from 282 to 898 Da. Therefore, the possibility of applying 
gradient elution was studied. 
2.2 Materials and methods 
Chemieals 
Por identification purposes, stock solutions of two purificd oligomers, namely E6 
(MW = 326) and E9 (MW = 458), were diluted to standard solutions of 1 mg/ml 
distilled water. A fresh stock solution of 10 mg PEG400 and 10 mg PEG600 per 
mi distilled water was prepared monthly. Por linearity testing this stock solution 
was diluted to standard solutions containing 0.1, 0.3, 0.5, 0.8, 1, 3, 5, and 8 mg 
PEG[400+600]/ml. A stock solution of radioactive, 14C-labelled PEG400 of 2 
mCi/ml was diluted to a standard solution of 5 p.Ci/ml. 
Sample pre-treatment 
Samples obtained from the Iiver erfusions were centrifuged and filtered 
simultaneously in specially designed micro test tubes (Eppendorf). 
Separation 
Two HPLC columns were used, namely a Techsphere C8 column (25 cm x 3.0 mm 
I.D.) and a Spherisorb C8 column (25 cm x 4.6 mm I.D.). Unless stated otherwise, 
the temperature of the column oven was 30°C. Mobile phases consisted of 
water/methanol or water/acetonitril mixtures. Injection volume was always 50 p.l. 
System 1 consisted of the Techsphere C8 column and a mobile phase of 
water/methanol = 70/30. System 2 consisted of the Spherisorb C8 column and an 
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eluent of water/methanol = 65/35. 
Dereetion 
Detection was carried out with an R401 differential refractometer (Waters 
Associates) or with an on-line radioactive detector (Radiomatic 500TR) . The usual 
temperature of the refractive index (RI) detector was set at 35°C, unless stated 
otherwise. 
2.3 Results 
Separation 
Identification. First of all, the oligomers of PEG400 were separated by means of 
isoeratic elution. The different peaks were identified by using standard solutions of 
two purified oligomers, namely E6 and E9. An overlay plot of chromatograms of 
E6, E9 and PEG400 is given in annex 2. Standard E6 is very pure but standard E9 
is less pure and slightly contaminated with at least 2 other oligomers, one of which 
is E6. 
Structural relationslzips. An increase in the MW of the oligomer causes an increase 
of the eetention time, independent of the system used (stationary and mobile phase). 
Therefore, complete separation of all peaks is feasible although the total run time 
increases exponentially. The elution of 11 oligomers on system 1 takes about 40 
minutes . The relationship between eetention time and MW is depicted in annex 3. 
Correcting the retention time (tR) of each oligomer for the dead volume (fa) gives 
the capacity factor 'k' of each oligomer {k = (tR-to)lfo}. Using the capacity factor 
instead of the retention time impraves the correlation with the MW of the 
oligomers, as can be seen in annex 4. The correlation coefficient (r) for the log-
linear relation between k and MW of 11 oligomers on HPLC system 1 is 0.9996. 
The correlation on a different HPLC system with more oligomers (n = 15) is even 
better: r = 0.9999. These results are depicted in annex 5. The hydrophobic 
character of a (series ot) compound(s) can be correlated with its Iiquid 
chromatographic behaviour. For example, the capacity factor of a series of 
compounds can be related to the n-octanol/water partition coefficient and HPLC can 
be used to determine the partition coefficient [1 0-12]. Officially, this relationship 
is limited to compounds with log P between 0 and 6 [ 10]. Therefore, the 
_r_elationship_between caQacity factor and molecular weight of PEG oligomers may 
not be based on hydrophobicity but on another phenomenon. Nevertheless, it is a 
very good relationship which deserves closer attention. 
Gradient elution. In order to improve the run time of approximately 45 minutes 
during isoeratic elution the feasability of a gradient elution was investigated. 
However, despite of a lot of attempts and changes of the chromatographic system, 
variations in the composition of the eluent all lead to an unacceptable drift of the 
baseline of the refractive index detector. On-line mixing of i.e. water and methanol 
caused to much base line drift although their difference in refractive index is as low 
as 0.004. The use of an on-line low or high pressure mixing chamber slightly 
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improved the situation but results were still unacceptable. This problem is related 
to the use of a refractive index detector (will be discussed in the next section). 
Deleetion 
One of the aims of this research was to investigate the feasibility of performing in 
vivo studies with non-radioactive labelled PEGs by applying an HPLC methad not 
based on radioactive detection. Due to the absence of UV -absorption of PEGs the 
detection was carried out with a refractometer, as had been applied by many other 
investigators. The limit of detection of standard solutions is dependent on the 
applied HPLC system and the MW of the oligomer. Applying HPLC system 2 and 
a mixture of 0.1 mg PEG400 and 0.1 mg PEG600 per mi water, eligomers E6 to 
E17 could be quantified. The limit of detection for E6 was approximately 5 J.tglml 
and the limit of quantitation is about 10 J.'g/ml. The disadvantages of refractive 
index detection became apparent after many different adaptations of the original 
HPLC set-up. Summarized, these disadvantages are: 
- sensitive to changes in temperature 
- sensitive to changes in pressure (and therefore in flow rate) 
- sensitive to variadons in the composition of the eluent 
- degassing of the mobile phase is crucial 
- only restricted back-pressure is allowed 
- lack of sensitivity (compared to other detection systems) 
Therefore, the determination of PEG eligomers with HPLC and refractive index 
detection is only possible with isoeratic elution and in order to obtain reproducible 
results many factors must be kept constant. 
Linearity 
Calibration curves were generated by measuring the peak areas of each oligomer 
(E5-E19) over a 30 tot 100-fold range ofpolymer concentrations. Mixtures of equal 
amounts of PEG400 and PEG600 were used. Calibration curves were linear for all 
eligomers over the range 0.1 - 3 mg/ml. The calibration curves are shown in 
annexes 6, 7 and 8. Calibration curves of E5-E12 deviated from linearity above 3 
mg PEG[400+600]/ml, although calibration curves of E13-E19 remained linear 
untill 10 mg PEG[400+600]/ml. These curves are depicted in annexes 9, 10 and 
11. Fortunately, as will be shown in the next chapter, outflow concentrations of 
PEG[400+600] into the hepatic vein of the isolated perfused rat livers were lower 
than 3 mg PEG[400+600]/ml. 
2. 4 Conclusions 
Due to the properties of a refractometer used on-line in an HPLC system it was not 
possible to apply gradient elution of PEG oligomers. The isoeratic elution of a large 
number of eligomers (n= 15) is possible but many factors like temperature, 
pressure, eluent composition must be kept constant. The achieved run time for one 
sample is approximately 45 minutes. 
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Calibration curves, based upon peak area, are linear over a concentratien range of 
0.1 to 3 mg PEG[400+600]/ml. The limit of detection for E6 was approximately 
5 J,tg/ml and the limit of quantitation is about 10 J,tglml. Oligomers E6 to E17 could 
be quantified in a mixture of 0.1 mg PEG400 and 0.1 mg PEG600 per ml water 
A very good log-linear relationship between molecular weight and capacity factor 
was found on two different HPLC systems. The investigated molecular weight 
range varied from 282 to 898 Da. It is not clear whether this correlation indicates 
that the hydrophobicity of these eligomers increases as molecular weight increases. 
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3. RAT LIVER PERFUSION. EXPERIMENT 1 
3.1 Introduetion 
Polyethylene glycols have been extensively used to study intestinal permeability, 
i.e. intestinal paracellular absorption, but no information is available on the 
permeability of these compounds in the liver. PEGs are mixtures of different 
eligomers and offer a set of molecules with different molecular weights and sizes. 
Especially the influence of molecular size on the permeability of these hydrophilic 
compounds in the rat Iiver is of interest for physiologically based pharmacokinetic 
modeling and drug development. 
In order to investigate the influence of molecular size on the dispersion profile and 
washout kinetics of different eligomers a perfusion of an isolated rat Iiver was 
performed. 
3. 2 Matcrials 
All reagents were of analytica! grade. The following stock solutions were used: 
Tritiated water: 25 mCi/ml 
14C-labelled sucrose: 0.1 mCi/ml 
PEG400: 2 mCi/ml 
PEG[400+600]: 5 mg PEG400 and 5 mg PEG600 per mi Krebs-Ringer buffer 
solution enriched with glucose. 
3. 3 Ex perimental design 
An experiment was designed in which the hepatic dispersion of PEG eligomers 
could be studied applying a bolus of 14C-labelled PEG400 and the washout kinetics 
of the eligomers could be investigated after an infusion with a mixture of cold 
PEG400 and PEG600. The infusion was carried out with cold PEGs because it 
would be far to expensive to use 14C-labelled PEG to obtain a steady state in a 
single-pass isolated perfused rat liver. Two radioactive labelled reference markers 
were used, namely tritiated water as a waterspace marker and 14C-labelled sucrose 
as an extracellular marker. 
In order to evaluate the intlucnee of the infusion with cold PEGs, the markers as 
well as 14C-labelled PEG400 were administered as a bolus befere and during the 
infusion with cold PEG. The lay-out of the ex perimental design is schematically 
shown in annex 12. 
A male Sprague-Dawley rat weighing 357 g was used in the first Iiver perfusion 
experiment. The isolated perfused in situ Iiver preparatien was the same as that 
described previously [13-15]. In short, under intraperitoneal anesthesia the bile duet 
was cannulated. After rapid cannulation and ligatien of the portal vein the liver was 
perfused at a flow rate of 15 milmin with Krebs-Ringer bicarbonate buffer 
containing glucose. Liver effluent was collected via a cannula inserted into the 
superior vena ca va tlll'ough the right atrium without interruption of portal perfusion. 
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Aftera stabilization period of 15 minutes, 50 J.Û of a mixture of tritiated water (0.5 
p.Ci) and 14C-Iabelled sucrose (0.0027 p.Ci) was injected as a bolus into the portal 
vein. An automatic turntable was activated simultaneously to collect the effluent at 
1-sec intervals for 1 min. Subsequently, samples were collected at 10-sec intervals 
for 1 min. During this minute the rate of outflow (liver effluent) was determined. 
The next 3 minutes were pooled into one final sample. Then 50 p.l of PEG400 (100 
p.Ci) was injected as a bolus into the portal vein. The total effluent was again 
collected for 5 min in the same manner as was done for the marker mixture. 
Thereafter, the liver was perfused with a mixture of 5 mg PEG400 and 5 mg 
PEG600 per ml Krebs-Ringer buffer solution. After 10 min of infusion the same 
bolus of marker mixture was injected and samples were collected as before. 
Subsequently, the same bolus of 14C-Iabelled PEG400 was injected and samples 
were collected as before. Five minutes after the last sample collection the PEG 
infusion was terminated and the liver was perfused with Krebs-Ringer buffer 
solution. Again the automatic turntable was activated simultaneously to collect the 
effluent at 2-sec intervals for 2 min and then at 5-sec intervals for 3 min. The total 
perfusion lasted 55 minutes. 
Viability of the liver was assessed by its gross appearance, flow recovery and bile 
production. The bile was collected approximately every 20 minutes. The wet liver 
weight was determined immediately after the experiment. 
The concentrations of the radiolabelled markers in the effluent samples were 
measured by a liquid seintillat ion counter after actdition of scintillant. Determination 
of the eligomers of 14C-labelled PEG400 was carried out by HPLC with on-line 
radioactivity detection (HPLC system 1) . The 'cold' eligomers were determined by 
HPLC with on-line refractive index detection (HPLC system 2). 
3.4 Results 
Visual observation of the liver throughout the experiment indicated no oedema. The 
wet liver weight was 14.1 g: 3.9 percent of total body weight. The outflow rates 
of liver and bile increased during the experiment, see table 1. 
The observed concentrations of cold eligomers after the infusion feil within the 
linear range of the calibration curve. The detection limit enabled the determination 
of eligomers E5 up to E18 for 3 minutes after cessation of the infusion. 
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Table 1. Outflow rates (mi/min) of liver .and bile effluent during the first liver 
perfusion. 
Organ Phase Compound Number of Period Flow rate ± 
observations (minutcs) s.d. 
Liver before infusion 3H2o+t4c_ 6 1 13.63 ± 1.0 
Sucrose 
Liver before infusion 14C-PEG400 6 1 13.93 ± 0.8 
Liver during infusion 3H2o+t4c_ 
Sucrose 
6 1 14.75 ± 0.5 
Liver during infusion 14C-PEG400 6 1 14.86 ± 0.8 
Bi ie before infusion N.A. 1 20 0.006 
Bi ie beforc and N.A. 1 25 0.008 
during infusion 
Bile during and N.A. 1 20 0.011 
after infusion 
N.A. = Not Applicable 
The outflow versus time profiles for the radiolabelled markers are shown in 
annexes 13-15. Unintentionally, a low dose of 14C-Iabelled sucrose was used. 
Nevertheless, it is obvious that 14C-labelled sucrose reached its maximum earlier 
than tritiated water and then decayed more quickly (see annex 13). There was little 
difference between the first part (ascending part) of the outflow curves of tritiated 
water befere and during the PEG infusion, resulting in approximately the same Lmax 
(see annex 14). After maximum was reached the elution of the secend bolus was 
slightly slO\ver than the first bolus of tritiated water. Surprisingly, the elution 
profile of the secend bolus of 14C-labelled sucrose was superimposed on a 
deseending slope (see annex 15). Apparently, some 14C-labelled radioactive 
material was still being eluted. It is not clear whether this was due to the previous 
bolus of 14C-labelled PEG400. Although different injection needies were used for 
the injection of markers and PEG400 some residual PEG400 might still have been 
present during the secend bolus of markers. After maximum was reached the 
elution of the second bolus was slightly slower than the first bolus of 14C-labelled 
sucrose. The elution profiles of the differefitl"4c-labelled eligomers of PEG4o=o"-------
were very similar. In annex 16 the outflow curves are shown of 4 oligomers, 
coveringa range of molecular weights of 326 (= E6) to 722 Da {= E15). There 
were some differences in lmax of each oligomer. Fitting the data using a ene-
campartment axial dispersion model will reveal if there is a relationship between 
tmax and molecular weight of the oligomers. The elution profile of PEG400 
eligomers after the secend bolus injection, during PEG[400+600] infusion, was 
slightly different (see annex 17). Aft er the maximum was reached the elution of all 
eligomers was slightly slower than after the first bolus of 14C-labelled PEG400. In 
genera!, the elution profile of the PEG eligomers resembied the outflow curves of 
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tritiated water, although the PEG400 oligomers were retained somewhat langer than 
tritiated water. However, the axial dispersion model parameters were nat 
established due to lack of time. 
After 10 minutesof infusion steady-state was reached as was indicated by analysing 
the levels of cold oligomers in samples taken just before, during and after the 
second bolus injection of the markers. After cessation of the infusion the different 
oligomers were washed out at approximately the same rate (see annex 18) . There 
was a tendency that as molecular weight increased the elution rate was increased. 
Detailed analysis of the available data will show if there were significant 
differences in the different elution rates. 
3. 5 Conclusions 
After the infusion with non-radioactive labelled PEGs the concentrations of the 
'cold' oligomers could be successfully determined with the developed HPLC 
methad (applying refractive index detection). 
The outflow curves of markers and PEG oligomers obtained in the second half of 
the experiment (during infusion with cold PEGs) were all slightly different from 
those in the first part of the experiment. Because liver and bile outflow rates 
increased during the experiment there is serious doubt on the viability of the liver 
during the experiment. lt is nat clear whether this was due to the PEG infusion or 
to the deterioration of the liver. 
The dispersion of PEG oligomers is quite similar to water, i.e. the oligomers do 
enter the liver cells, in contrast to absorption processes accuring in intestinal cells. 
If the PEG400 oligomers were retained somewhat langer than tritiated water this 
would indicate a larger volume of distribution of the PEG400 oligomers. In 
genera!, there were no clear differences in dispersion and elution of the tested 
oligomers. 
In order to draw unequivocal conclusions these kind of experiments have to be 
repeated several times. Although there was only little time left to perfarm another 
experiment it was decided to carry out another liver perfusion for two important 
reasons. First of all, for future experimentation it is vital to know whether the 
infusion with a relatively high dose of cold PEGs affected the viability of the liver. 
Secondly, it was necessary to know whether the occurrence of residu al 14C 
radioactivity during the second bolus injection of the markers, could be avoided 
in future experiments. Therefore, another liver perfusion was carried out and as 
many samples as possible were analysed to rule out the above-mentioned 
uncertainties. 
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4. RAT LIVER PERFUSION. EXPERIMENT 2 
4.1 Introduetion 
The first rat Iiver perfusion was repeated and based upon the results of that liver 
perfusion, some changes were made in the experimental design. Special attention 
was given to overcome residual radioactivity during the experiment (see items 1 
and 2) and some minor adjustments were made to allow a better interpretation of 
the obtained data (see items 3, 4 and 5). 
1. Precautions were taken to avoid cross-contamination of markers and PEG 
eligomers (rinsing of injection valve and connected tubing). 
2. The period between the first bolus injection of 14C-labelled PEG400 and the 
start of the infusion with cold eligomers was increased to 10 minutes. 
3. The dose of 14C-Iabelled sucrose was increased to 0.08 t-tCi. 
4. The automatic turntables were started after the markers and PEG400 were 
injected and after the infusion was started (compared to the first experiment this 
means a shortening of the lag time with approximately 3 seconds). 
5. Outflow rates of liver effluent were determined during 3 minutes over intervals 
of 30 seconds insteadof during 1 minute over periods of 10 seconds. 
4.2 Materials 
The same reagents and stock solutions were used as in the first liver perfusion. 
4.3 Experimental design 
The hepatic dispersion of PEG oligomers was studied applying a bolus of 14C-
Iabelled PEG400 and after an infusion with a mixture of cold PEG400 and PEG600 
the washout kinetics of the oligomers were investigated. Tritiated water and 14C-
labelled sucrose were used as radioactive labelled reference markers. 
In order to evaluate the influence of the infusion with PEGs thc markers as well as 
14C-Iabelled PEG400 were administered as a bolus before and during the infusion 
with cold PEG. Compared to the first experiment, the washout of the first bolus of 
14C-labelled PEG400 was prolonged with 5 minutes and the total duration of the 
second perfusion was 60 minutes. The lay-out of the experimental design is 
schematically shown in annex 12. 
A male Sprague-Dawley rat weighing 298 g was used in the second liver perfusion 
experiment. The in situ Iiver preparatien was the same as in the first experiment. 
Aftera stabilization period of 15 minutes, 50 t-tl of a mixture of tritiated water (0.5 
ttCO and 14C-labelled sucrose (0.08 ~-tCi) was injected as a bolus into the portal 
vein. An automatic turntable was activated immediately after the mixture was 
injected to collect the effluent at 1-sec intervals for 1 min. Subsequently, samples 
were collected at 10-sec intervals for 1 min and then at 30-sec intervals for a 
further 3 minutes. During the last 3 minutes the rate of outflow (Iiver effluent) was 
determined. Then 50 ttl of PEG400 (100 ttCi) was injected as a bolus into the 
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portal vein. The total effluent was again collected for 5 min in the same manner as 
was done for the marker mixture. Thereafter, the liver was perfused with buffer 
solution for another 5 minutes before the liver was perfused with a mixture of 5 mg 
PEG400 and 5 mg PEG600 per ml Krebs-Ringer buffer solution. After 10 min of 
infusion the sa me bolus of marker mixture was injected and samples were collected 
as before. Subsequently, the same bolus of 14C-labelled PEG400 was injected and 
samples were collected as before . Five minutes after the last sample collection the 
PEG infusion was terminated and the liver was perfused with Krebs-Ringer buffer 
solution. The automatic turntable was activated irrunediately after the buffer 
solution was switched to collect the effluent at 2-sec intervals for 2 min and then 
at 5-sec intervals for 3 min. Now, the total perfusion lasted 60 minutes. 
Viability of the liver was assessed by its gross appearance, flow recovery and bile 
production. The bile was collected approximately every 20 minutes. The wet liver 
weight was determined irrunediately after the experiment. 
The concentrations of the radiolabelled markers in the effluent samples were 
measured by a liquid scintillation counter after actdition of scintillant. Determination 
of the oligomers of 14C-labelled PEG400 was carried out by HPLC with on-line 
radioactivity detection (HPLC system 1). The 'cold' oligomers were determined by 
HPLC with on-line refractive index detection (HPLC system 2). 
4.4 Results 
Visual inspeetion of the liver during the experiment indicated no oedema. The wet 
liver weight was 13 .7 g: 4.6 percent of total body weight. The outflow rates of 
liver and bile were constant during the experiment, see table 2. 
Table 2. Outflow rates (mi/min) of liver and bile effluent during the second liver 
perfusion. 
Organ Phasc Compound Number of Period Flow rate ± 
observations (minutes) s .d. 
Liver before infusion 3H2o+t4c_ 6 3 13.86 ± 0 .3 
Sucrose 
Livcr before infusion 14C-PEG400 6 3 13.83 ± 0 .2 
Liver during-infusion -3H20 + IAe-- 6 -- 3 - 13.96--±-0.2 
Sucrose 
Liver during infusion 14C-PEG400 6 3 13 .92 ± 0.3 
Bile before infusion N.A. 1 20 0 .006 
Bilc before and N.A. 1 25 0.006 
during infusion 
Bile during and N.A. 1 25 0.007 
afler infusion 
N.A . = Not Applicable 
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The outflow versus time profiles for the radiolabelled markers are shown in 
annexes 19-21. The adjustment of the dose of 14C-Iabelled sucrose allowed a better 
interpretation of the obtained data. Clearly, 14C-Iabelled sucrose reached its 
maximum earlier than tritiated water and subsequently decayed more quickly (see 
annex 19). Except fora difference in lag time there was no significant difference 
in the outflow of tritiated water before and during the infusion (see annex 20). The 
outflow of 14C-labelled sucrose was also not affected by the infusion with a 
relatively high dose of cold PEG oligomers (see annex 21). As intended, the lag 
time was shortened for both markers with a few seconds compared to the first liver 
perfusion. Apparently, the problem with the residual radioactivity, encountered in 
the first experiment, was avoided by the precautionary measures. Unfortunately, 
there was no time left to analyse the samples of the elution profiles of the different 
14C-labelled oligomers of PEG400. 
Steady-state was reached after 10 minutesof infusion as was indicated by analysing 
the levels of cold oligomers in samples taken just before, during and after the 
second bolus injection of the markers. After cessation of the infusion the different 
oligomers were washed out at approximately the same rate (see annex 22). Detailed 
analysis of the available data will show if there were significant differences in the 
different elution rates. 
4.5 Conclusions 
The outflow curves of the applied markers obtained in the second half of the 
experiment (during infusion with cold PEGs) were not significantly different from 
those in the first part of the experiment. Liver and bile outflow rates were constant 
during this experiment and there were no indications that deterioration of the liver 
had occurred during this experiment. Therefore, it can be concluded that the 
infusion with a relatively high dose of cold PEGs did not affect the viability of the 
liver. This is an important prerequisite for the design of future experiments. 
No residual radioactivity was observed during the experiment after taking the 
necessary precautions to avoid cross-contamination of markers and PEG oligomers 
and increasing the washout period of the first bolus injection of 14C-labelled 
PEG400. 
In general, there were no striking differences in the washout kinetics of the tested 
oli om ers aft er infusion with a mixture of PEG400 and PEG600. 
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5. GENERAL CONCLUSIONS AND DISCUSSION 
Determination of PEG oligomers with HPLC 
One of the aims of this research was to investigate the feasibility of performing in 
vivo studies with non-radioactive labelled PEGs by applying an HPLC method not 
based on radioactive detection. Due to the absence of UV-absorption of PEGs the 
detection was carried out with a refractometer. Fifteen oligomers (E6-E19) could 
be studied simultaneously in the in situ rat liver perfusions by the application of a 
mixture of PEG400 and PEG600. Therefore, an HPLC method was developed 
successfully to analyse 15 compounds in one run within an acceptable run time. 
Despite of a lot of attempts, gradient elution of PEG oligomers was not possible 
due to the properties of a refractometer when used on-line in an HPLC system. 
Calibration curves, based upon peak area, are linearover a concentration range of 
0.1 to 3 mg PEG[400+600]/ml. The limit of detection for E6 was approximately 
5 J.tglml and the limit of quantitation is a bout 10 J.tglml. Oligomers E6 to E17 could 
be quantified in a mixture of 0.1 mg PEG400 and 0.1 mg PEG600 per mi water. 
A very good log-linear relationship between molecular weight and capacity factor 
was found on two different HPLC systems. The investigated molecular weight 
range varied from 282 to 898 Da. lt is not clear whether this correlation indicates 
that the hydrophobicity of these oligomers increases as molecular weight increases. 
Rat /iver pe1jusions 
Another aim was to study the influence of molecular size on the permeability of 
different oligomers of PEG in the isolated perfused rat liver. It was concluded that 
the infusion with a relatively high dose of cold PEGs did not affect the viability of 
the liver. Therefore, in situ rat Iiver perfusions can be designed in which bolus 
injections of 14C-Iabelled PEG can be combined with an infusion of cold PEG. The 
dispersion of PEG oligomers is quite similar to water, i.e. the oligomers enter the 
liver cells and distribute and elute in a similar manner as water. There were no 
clear differences in dispersion and elution between the different oligomers tested. 
Detailed kinetic and statistica! analysis of the data will have to be performed to 
discriminate significant differences between oligomers and to reveal relationships 
_________ between molecular weight and dispersion or disposition. However, the investigated 
range of molecular weights, from 282 to 810 Da, might be too small to detect any 
significant differences in dispersion and disposition. 
Future research 
This research has led to a better understanding of kinetic processes accuring in the 
rat liver, especially the influence of molecular size on the dispersion profile and 
washout kinetics of PEG oligomers. This kind of fundamental research leads to an 
improved knowledge of the variations in transit time of compounds on passage 
through a tissue, i.c. the liver. Extension and refinement of the physiologically 
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based pharmacokinetic rnadeis will strengthen the predictive power of these models, 
in particular with respect to identifying target site(s) of drugs. Future research, 
carried out at RIKILT-DLO, will concentrate on PB-PK rnadeis and its application 
for descrihing and predicting the kinetic behaviour of biologically active (non-) 
nutrients and drugs in man and food-producing animals. This research has lead to 
a better understanding of essential aspects of PB-PK rnadeling and I am thankful 
to those who made this possible: the Netherlands Organisation for Scientific 
Research (NWO), in collaboration with the British Council, and prof. dr. Rowland 
from the Manchester University in the UK. 
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ANNEX 1. Molecular structures and weights of tested PEG oligomers. 
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ANNEX 2. Overlay plot of chromatograms of standard solutions of PEG400 and 
purified E6 and E9. 
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ANNEX 3. Relationship between molecular weight and retentien time of eligomers of 
PEG400 (E6-E16) on HPLC system 1. 
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ANNEX 4. Log-linear relationship between molecular weight and capacity factors of 
oligomers of PEG400 (E6-E16) on HPLC system 1. 
Molecular weight vs. H PLC elution 
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ANNEX 5 . Log-linear relationship between molecular weight and capacity factors of 
eligomers of a mixture of PEG400 and PEG600 (E5-E19) on HPLC system 
2. 
Molecular weight vs. H PLC elution of 
PEG400+600 (E5-E19) on system 2 
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ANNEX 6. Calibration curves for eligomers E5-E9 of a mixture of PEG400 and 
PEG600 in the range of 0.1 - 3 mg PEG[400+600] mg/ml. 
Calibration curves of five eligomers 
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ANNEX 7. Calibration curves for oligomers E10-E14 of a mixture of PEG400 and 
PEG600 in the range of 0.1 - 3 mg PEG[400+600] mg/ml. 
Calibration curves of five oligomers 
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ANNEX 8. Calibration curves for oligomers E15-E19 of a mixture of PEG400 and 
PEG600 in the range of 0.1 - 3 mg PEG[400+600] mg/ml. 
Calibration curves of five oligomers 
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ANNEX 9. Calibration curves for oligomers E5-E9 of a mixture of PEG400 and 
PEG600 in the range of 0 .1 - 10 mg PEG[ 400 + 600] mg/ml. 
Calibration curves of five oligomers 
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ANNEX 10. Calibration curves for oligomers E10-E14 of a mixture of PEG400 and 
PEG600 in the range of 0.1 - 10 mg PEG[400+600] mg/ml. 
Calibration curves of five eligomers 
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ANNEX 11. Calibration curves for oligomers E15-E19 of a mixture of PEG400 and 
PEG600 in the range of 0.1 - 10 mg PEG[400+600] mg/ml. 
Calibration curves of five oligomers 
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ANNEX 12. Lay-out of the in situ rat liver perfusions using a bolus of 14C-labelled 
PEG400 combined with an infusion of a mixture of 'cold' PEG400 and 
PEG600. 
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ANNEX 13. Outflow curves of the first bolus of tritiated water and 14C-labelled sucrose 
in the first rat liver perfusion. 
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ANNEX 14. Outflow curves of the first and second bolus of tritiated water in the first 
rat Iiver perfusion. 
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ANNEX 15 . Outflow curves of the first and second bolus of 14C-labelled sucrose in the 
first rat liver perfusion. 
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ANNEX 16. Elution profile of four different oligomers after the first bolus of 14c_ 
labelled PEG400 in the first rat Iiver perfusion. 
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ANNEX 17. Elution profile of four different oligomers after the second bolus of 14C-
labelled PEG400 in the first rat liver perfusion. 
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ANNEX 18. Washout curves of five different oligomers in the first rat liver perfusion. 
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ANNEX 19. Outflow curves of the first bolus of tritiated water and 14C-labelled sucrose 
in the second rat liver perfusion. 
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ANNEX 20. Outflow curves of the first and second bolus of tritiated water in the second 
rat liver perfusion. 
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ANNEX 21. Outflow curves of the first and second bolus of 14C-Iabelled sucrose in the 
second rat Iiver perfusion. 
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ANNEX 22. Washout curves of five different oligomers in the second rat liver perfusion. 
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